Finance News Network

Interviews

Rural Funds Group (ASX:RFF) FY22 Financial Results Summary

30 November 2022 - James Powell, the General Manager - Investor Relations, Corporate Affairs and Sustainability of the Rural Funds Group Limited (ASX:RFF), presents on the group's …

Immutep (ASX:IMM) discusses a transformative year for LAG-3 therapies

28 Nov 2022 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses the LAG-3 landscape, the company's portfolio of therapies, encouraging data from the 2022 SI…

BluGlass demonstrates feasible reliability of laser diodes

25 Nov 2022 - BluGlass Limited (ASX:BLG) President Jim Haden discusses achieving a key reliability milestone for the company's laser diodes.

The alternative to lithium

23 Nov 2022 - Altech Chemicals Limited (ASX:ATC) CFO Martin Stein discusses the recent joint venture with Fraunhofer IKTS and the CERENERGY solid state sodium alumina battery.

Radiopharm Theranostics (ASX:RAD) to commence NSCLC trial in Australia

22 Nov 2022 - Radiopharm Theranostics Limited (ASX:RAD) Managing Director and CEO Riccardo Canevari discusses the progress of the company's brain, lung and prostate cancer therapie…

Genetic Signatures (ASX:GSS) - detecting infectious diseases in high-throughput lab workflows

17 Nov 2022 - Genetic Signatures Limited (ASX:GSS) CEO and Director Dr John Melki discusses the company's technology, business model, 2022 highlights and outlook.

Arovella Therapeutics (ASX:ALA) - tackling blood cancers and solid tumours

15 Nov 2022 - Arovella Therapeutics Limited (ASX:ALA) Managing Director and CEO Dr Michael Baker provides an update on the company.

OncoSil Medical (ASX:OSL) - targeted therapy for pancreatic cancer

15 Nov 2022 - OncoSil Medical Limited (ASX:OSL) Non-Executive Director Brian Leedman discusses joining the board of OncoSil and receiving CE mark approval for the company's therapy…

K2fly (ASX:K2F) - providing ESG solutions for top 50 mining companies

11 Nov 2022 - K2fly Limited (ASX:K2F) CEO Nic Pollock discusses K2F's progress and milestones over the past year.

Chimeric Therapeutics (ASX:CHM) enters research agreement to advance cell therapy portfolio

04 Nov 2022 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow discusses the company's new agreement with Case Western Reserve University.

Antisense Therapeutics (ASX:ANP) discusses upcoming AGM resolutions and new management appointment

03 Nov 2022 - Antisense Therapeutics Limited (ASX:ANP) Chair, Dr Charmaine Gittleson, and new Chief Commercial Officer, Dr Anthony Filippis, discuss Antisense's progress, attractin…

Novonix (ASX:NVX) receives US$150m grant for EV battery production

02 Nov 2022 - Novonix Limited (ASX:NVX) CEO Dr Chris Burns discusses news following the company's AGM, including the appointment of new directors and the expansion of the company's…

Market update with Shaw and Partners, October 2022

31 Oct 2022 - Shaw and Partners Chief Investment Officer Martin Crabb discusses the market outlook, giving general advice on investment implications.

icetana (ASX:ICE) discusses Macnica deal and new product launch

27 Oct 2022 - icetana Limited (ASX:ICE) CEO and Managing Director Matt Macfarlane discusses the company's recent deal with Japanese group Macnica and the launch of a new product.

Immutep (ASX:IMM) receives fast track designation from FDA

12 Oct 2022 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses the FDA fast track designation received in first-line non-small cell lung cancer, the compan…

Technology giant Macnica takes strategic investment in icetana (ASX:ICE)

12 Oct 2022 - icetana (ASX:ICE) CEO and Managing Director Matt Macfarlane discusses revenue growth, the company's strategic placement to Macnica, changes to the share registry and …

VRX Silica (ASX:VRX) discusses the demand for glass

12 Oct 2022 - VRX Silica Limited (ASX:VRX) Managing Director Bruce Maluish discusses the global demand for glass and the burgeoning silica sand sector in Australia.

Stealth Global (ASX:SGI) discusses 2025 strategy

07 Oct 2022 - Stealth Global Holdings Limited (ASX:SGI) Group Managing Director Michael Arnold discusses the business offering, M&A activity, clients, 2025 strategy and financial t…

QX Resources (ASX:QXR) developing hard rock lithium assets in WA

05 Oct 2022 - QX Resources Limited (ASX:QXR) Managing Director Stephen Promnitz discusses what brought him to QXR, and the company's assets and development stage.

Etherstack (ASX:ESK) signs agreements with Samsung and Nokia

05 Oct 2022 - Etherstack Limited (ASX:ESK) CEO and Executive Director David Deacon discusses recent agreements with Samsung and Nokia and the outlook for the months ahead.

Knosys (ASX:KNO) discusses FY22 results

04 Oct 2022 - Knosys Limited (ASX:KNO) Managing Director John Thompson discusses FY22 highlights, revenue drivers, growth investments, hybrid working tailwinds and the outlook for …

WT Financial Group (ASX:WTL) discusses full-year statutory accounts

30 Sep 2022 - WT Financial Group Limited (ASX:WTL) Founder and Managing Director Keith Cullen discusses financial highlights, 2023 guidance, the value of scale, the vision for fina…

Arovella Therapeutics (ASX:ALA) partners with Imugene (ASX:IMU)

29 Sep 2022 - Arovella Therapeutics Limited (ASX:ALA) Managing Director and CEO Michael Baker discusses the company's collaboration with Imugene to combine therapies.

Meeka Metals (ASX:MEK) developing gold and rare earths projects

28 Sep 2022 - Meeka Metals Limited (ASX:MEK) Managing Director and CEO Tim Davidson discusses recent gold and rare earths results and the outlook for the next year.

European Metals (ASX:EMH) positioned to supply lithium to the EU

26 Sep 2022 - European Metals Holdings Limited (ASX:EMH) discusses its Cinovec project, the largest hard rock lithium resource in Europe.

Prior Page Next Page